Cargando…

Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study

OBJECTIVE: Uterine fibroids can cause a variety of symptoms in women, from heavy menstrual bleeding and dysmenorrhea to bulk symptoms. The Uterine Fibroid Symptom and health-related Quality Of Life questionnaire (UFS-QOL) is a patient-reported outcome measure developed for assessing fibroid-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Keizer, Alieke L, van Kesteren, Paul J M, Terwee, Caroline, de Lange, Maria E, Hehenkamp, Wouter J K, Kok, Helen S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611425/
https://www.ncbi.nlm.nih.gov/pubmed/34815284
http://dx.doi.org/10.1136/bmjopen-2021-052664
_version_ 1784603293037625344
author Keizer, Alieke L
van Kesteren, Paul J M
Terwee, Caroline
de Lange, Maria E
Hehenkamp, Wouter J K
Kok, Helen S
author_facet Keizer, Alieke L
van Kesteren, Paul J M
Terwee, Caroline
de Lange, Maria E
Hehenkamp, Wouter J K
Kok, Helen S
author_sort Keizer, Alieke L
collection PubMed
description OBJECTIVE: Uterine fibroids can cause a variety of symptoms in women, from heavy menstrual bleeding and dysmenorrhea to bulk symptoms. The Uterine Fibroid Symptom and health-related Quality Of Life questionnaire (UFS-QOL) is a patient-reported outcome measure developed for assessing fibroid-related symptoms in a standardised way. Our aim was to translate and validate the UFS-QOL in Dutch. DESIGN: Validation study. SETTING: Patients were recruited by a gynaecologist at the outpatient clinic. PARTICIPANTS: Women with uterine fibroids. METHODS: The UFS-QOL was translated into Dutch (UFS-QOL NL) and validated through testing construct validity (comprising of structural validity and hypotheses testing), reliability, responsiveness and interpretability, assessing floor and ceiling effects and minimal important change. An option to answer ‘not applicable’ was added to the translated questionnaire. RESULTS: 191 women with uterine fibroids completed the UFS-QOL NL at baseline, after 2 weeks and after 3 months. The questionnaire retained the same factor structure after translation (Comparative Fit Index 0.94–0.95; Tucker-Lewis fit Index 0.93–0.95; Root Mean Square Error of Approximation 0.10–0.11) and correlations to other questionnaires (RAND 36, Hospital Anxiety and Depression Scale and Golombok Rust Inventory of Sexual Satisfaction) were generally moderate, as hypothesised (Pearson’s r 0.3–0.7). We found a sufficient reliability with intraclass correlation coefficients of approximately 0.8–0.9 for all subscales. Responsiveness was sufficient when testing hypotheses comparing women who had surgery with those who did not. Cronbach’s alpha was higher than 0.7 for all subscales, indicating sufficient internal consistency and there were no concerns about floor or ceiling effects. Minimal important change could not be calculated due to low correlation between the different subscales and the anchor question. CONCLUSIONS: The results support the measurement properties of the Dutch UFS-QOL for assessing fibroid-related symptoms and health-related quality of life in Dutch women with uterine fibroids.
format Online
Article
Text
id pubmed-8611425
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86114252021-12-10 Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study Keizer, Alieke L van Kesteren, Paul J M Terwee, Caroline de Lange, Maria E Hehenkamp, Wouter J K Kok, Helen S BMJ Open Obstetrics and Gynaecology OBJECTIVE: Uterine fibroids can cause a variety of symptoms in women, from heavy menstrual bleeding and dysmenorrhea to bulk symptoms. The Uterine Fibroid Symptom and health-related Quality Of Life questionnaire (UFS-QOL) is a patient-reported outcome measure developed for assessing fibroid-related symptoms in a standardised way. Our aim was to translate and validate the UFS-QOL in Dutch. DESIGN: Validation study. SETTING: Patients were recruited by a gynaecologist at the outpatient clinic. PARTICIPANTS: Women with uterine fibroids. METHODS: The UFS-QOL was translated into Dutch (UFS-QOL NL) and validated through testing construct validity (comprising of structural validity and hypotheses testing), reliability, responsiveness and interpretability, assessing floor and ceiling effects and minimal important change. An option to answer ‘not applicable’ was added to the translated questionnaire. RESULTS: 191 women with uterine fibroids completed the UFS-QOL NL at baseline, after 2 weeks and after 3 months. The questionnaire retained the same factor structure after translation (Comparative Fit Index 0.94–0.95; Tucker-Lewis fit Index 0.93–0.95; Root Mean Square Error of Approximation 0.10–0.11) and correlations to other questionnaires (RAND 36, Hospital Anxiety and Depression Scale and Golombok Rust Inventory of Sexual Satisfaction) were generally moderate, as hypothesised (Pearson’s r 0.3–0.7). We found a sufficient reliability with intraclass correlation coefficients of approximately 0.8–0.9 for all subscales. Responsiveness was sufficient when testing hypotheses comparing women who had surgery with those who did not. Cronbach’s alpha was higher than 0.7 for all subscales, indicating sufficient internal consistency and there were no concerns about floor or ceiling effects. Minimal important change could not be calculated due to low correlation between the different subscales and the anchor question. CONCLUSIONS: The results support the measurement properties of the Dutch UFS-QOL for assessing fibroid-related symptoms and health-related quality of life in Dutch women with uterine fibroids. BMJ Publishing Group 2021-11-23 /pmc/articles/PMC8611425/ /pubmed/34815284 http://dx.doi.org/10.1136/bmjopen-2021-052664 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Obstetrics and Gynaecology
Keizer, Alieke L
van Kesteren, Paul J M
Terwee, Caroline
de Lange, Maria E
Hehenkamp, Wouter J K
Kok, Helen S
Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study
title Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study
title_full Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study
title_fullStr Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study
title_full_unstemmed Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study
title_short Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study
title_sort uterine fibroid symptom and quality of life questionnaire (ufs-qol nl) in the dutch population: a validation study
topic Obstetrics and Gynaecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611425/
https://www.ncbi.nlm.nih.gov/pubmed/34815284
http://dx.doi.org/10.1136/bmjopen-2021-052664
work_keys_str_mv AT keizeraliekel uterinefibroidsymptomandqualityoflifequestionnaireufsqolnlinthedutchpopulationavalidationstudy
AT vankesterenpauljm uterinefibroidsymptomandqualityoflifequestionnaireufsqolnlinthedutchpopulationavalidationstudy
AT terweecaroline uterinefibroidsymptomandqualityoflifequestionnaireufsqolnlinthedutchpopulationavalidationstudy
AT delangemariae uterinefibroidsymptomandqualityoflifequestionnaireufsqolnlinthedutchpopulationavalidationstudy
AT hehenkampwouterjk uterinefibroidsymptomandqualityoflifequestionnaireufsqolnlinthedutchpopulationavalidationstudy
AT kokhelens uterinefibroidsymptomandqualityoflifequestionnaireufsqolnlinthedutchpopulationavalidationstudy